The underlying molecular pathology of cancer of the exocrine pancreas in humans and animal models of the disease is poorly understood, particularly with regard to the role of tumor suppressor gene (TSG) alterations in its development and malignant progression. The proposed studies will characterize the frequency and nature of molecular alterations in the p53, Rb-1, and DCC TSGs in human sporadic and familial cases of pancreatic cancer and their relationship to the clinicopathologic presentation of the disease and patient survival status. The TSGs will be examined by immunochemical and molecular approaches in a panel of tumor-derived cell lines and fresh frozen and archival tumor material. The role of these TSGs in pancreatic tumorigenesis, in vivo invasiveness, metastatic spread, and tumor morphological and secretory differentiation will be examined in TSG replacement studies in tumor cell lines in which the endogenous TSG(s) is (are) mutated or altered in their expression. In order to understand the role of TSG alterations in the development of human pancreatic cancer, in which early and intermediate lesions are rare or absent, the N-nitrosobis (2-oxopropyl)amine (-BOP)-induced ductal pancreatic carcinoma model in syrian hamsters will be utilized as a paradigm for studying the temporal sequence of molecular alterations during human pancreatic tumorigenesis based upon its morphological, biological, and molecular biological correlates with the human cancer. Collectively, these studies will provide a greater understanding of the molecular pathology of pancreatic cancer and the role and potential prognostic significance of several TSGs in the multi-step process of pancreatic tumorigenesis in humans and a highly relevant animal model of the disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA060735-03
Application #
2101492
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1993-07-01
Project End
1998-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Berger, D H; Chang, H; Wood, M et al. (1999) Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status. Cancer 85:326-32
Ruggeri, B A; Huang, L; Wood, M et al. (1998) Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol Carcinog 21:81-6
Lang, D; Miknyoczki, S J; Huang, L et al. (1998) Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells. Oncogene 16:1593-602
Ruggeri, B A; Huang, L; Berger, D et al. (1997) Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Cancer 79:700-16
Huang, L; Goodrow, T L; Zhang, S Y et al. (1996) Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Cancer Res 56:1137-41
Huang, L; Lang, D; Geradts, J et al. (1996) Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Mol Carcinog 15:85-95
Miknyoczki, S J; Klein-Szanto, A J; Ruggeri, B A (1996) Neurotrophin-Trk receptor interactions in neoplasia: a possible role in interstitial and perineural invasion in ductal pancreatic cancer. Crit Rev Oncog 7:89-100
Clapper, M L; Wood, M; Leahy, K et al. (1995) Chemopreventive activity of Oltipraz against N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters. Carcinogenesis 16:2159-65